12:00 AM
 | 
Jun 11, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Iluvien regulatory update

pSivida said the Portuguese National Authority of Medicines and Health Products approved Iluvien to treat vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. The MAA for...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >